Ernst & Young

FLJ Group Limited Announces Appointment of Directors

Retrieved on: 
Friday, December 22, 2023

Ms. Zhou has served as executive director of investment banking division of Gujia (Beijing) Technology Co., Ltd. since November 2020.

Key Points: 
  • Ms. Zhou has served as executive director of investment banking division of Gujia (Beijing) Technology Co., Ltd. since November 2020.
  • Ms. Zhou was a senior financial product manager and CEO assistant at a FinTech company named JianLC from 2018 to 2020.
  • From November 2015 to December 2017, Ms. Zhou worked as a manager of FinTech division in Hfax.com.
  • Prior to that, Ms. Zhou was the senior project manager of financial business division in Horizon Research Group from May 2012 to November 2015.

Burning Rock Announces Results of 2023 Annual General Meeting

Retrieved on: 
Wednesday, December 20, 2023

GUANGZHOU, China, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that all shareholder resolutions proposed at the Company’s 2023 annual general meeting held today were duly passed.

Key Points: 
  • GUANGZHOU, China, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that all shareholder resolutions proposed at the Company’s 2023 annual general meeting held today were duly passed.
  • Specifically, the shareholders passed the following resolutions:
    To ratify the appointment of Ernst & Young Hua Ming LLP as auditor of the Company for the fiscal year ending December 31, 2023 and to authorize the directors of the Company to determine the remuneration of the auditor;
    To re-elect Wendy Hayes, Min-Jui Richard Shen and Zhihong (Joe) Zhang as directors of the Company; and
    To authorize each of the directors of the Company to take any and all action that might be necessary to effect the foregoing resolutions as such director, in his or her absolute discretion, thinks fit.

Danforth Advisors Names Dan Dehner Managing Director

Retrieved on: 
Thursday, December 14, 2023

WALTHAM, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Danforth Advisors, LLC, today announced the appointment of Dan Dehner as Managing Director, overseeing growth in both emerging and established life science hubs where companies increasingly seek fractional resources across corporate and clinical functions.

Key Points: 
  • WALTHAM, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Danforth Advisors, LLC, today announced the appointment of Dan Dehner as Managing Director, overseeing growth in both emerging and established life science hubs where companies increasingly seek fractional resources across corporate and clinical functions.
  • Dehner brings more than 20 years of experience to the role, including strategic advisory, accounting and auditing services for private and public life science companies of all sizes and stages.
  • “We’re excited to welcome Dan in this newly created position, aiming to reach and fill more gaps for life science companies in an expertly managed and capital efficient way,” said Chris Connors, Chief Executive Officer of Danforth Advisors.
  • He previously managed an independent accounting services practice and spent over ten years with Big 4 accounting firms Ernst & Young and KPMG.

Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer

Retrieved on: 
Tuesday, December 12, 2023

SAN DIEGO, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced the appointment of Jerry DeCiccio, CPA, MBA, as Chief Financial Officer.

Key Points: 
  • SAN DIEGO, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced the appointment of Jerry DeCiccio, CPA, MBA, as Chief Financial Officer.
  • Mr. DeCiccio brings more than 40 years of financial industry experience to the Company, which includes executive roles at publicly traded companies and Ernst & Young.
  • Mr. DeCiccio also served in senior financial roles at Parker Hannifin Corp. (NYSE), Waste Management Inc. (NYSE), and Newport Corp. (NASDAQ).
  • “In the same breath, we are thrilled to have Jerry join our team as we shift focus toward the clinical advancement of Sigyn Therapy and unlocking the value of our therapeutic pipeline.”
    Mr. DeCiccio stated, “I am very excited to join the Sigyn Therapeutics team.

American Lithium Announces Appointment of New Auditor

Retrieved on: 
Friday, December 8, 2023

(“American Lithium” or the “Company”) (TSX-V: LI | Nasdaq: AMLI | Frankfurt: 5LA1 ) is pleased to announce the engagement of Davidson & Company LLP, Chartered Professional Accountants (“Davidson”), as auditor of the Company for the 2024 fiscal year.

Key Points: 
  • (“American Lithium” or the “Company”) (TSX-V: LI | Nasdaq: AMLI | Frankfurt: 5LA1 ) is pleased to announce the engagement of Davidson & Company LLP, Chartered Professional Accountants (“Davidson”), as auditor of the Company for the 2024 fiscal year.
  • American Lithium is actively engaged in the development of large-scale lithium projects within mining-friendly jurisdictions throughout the Americas.
  • Forward-looking statements in this news release include, but are not limited to, statements regarding the business plans, expectations and objectives of American Lithium.
  • American Lithium undertakes no obligation to update forward-looking statements except as required by applicable securities laws.

CFOs Respond to the Call for Greater Private Sector Investment in Climate Action at COP28

Retrieved on: 
Tuesday, December 5, 2023

Dubai, United Arab Emirates, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today, during the SDG Investment Forum at COP28, the UN Global Compact CFO Coalition for the SDGs demonstrated the importance of corporate investments and financing for climate action, effectively heeding increasingly louder calls for greater private sector investment.

Key Points: 
  • Dubai, United Arab Emirates, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today, during the SDG Investment Forum at COP28, the UN Global Compact CFO Coalition for the SDGs demonstrated the importance of corporate investments and financing for climate action, effectively heeding increasingly louder calls for greater private sector investment.
  • Corporations are expected to be the largest direct investors in climate change mitigation, accounting for roughly one-third of the total investment needed between now and 2050, which some estimate could amount to US$ 275 trillion.
  • Private climate financing must play a pivotal role as emerging markets and developing economies seek to curb greenhouse gas emissions and contain climate change while coping with its effects.
  • The Forward Faster initiative aims to mobilize private sector action where it can collectively make the biggest, fastest impact by 2030, focusing on gender equality, climate action, living wage, water resilience and finance and investments.

Sportradar Appoints Jim Bombassei as Senior Vice President, Investor Relations and Corporate Finance

Retrieved on: 
Monday, December 4, 2023

NEW YORK and ST. GALLEN, Switzerland, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sportradar (NASDAQ: SRAD) today announced the appointment of Jim Bombassei as Senior Vice President, Investor Relations and Corporate Finance, effective immediately.

Key Points: 
  • NEW YORK and ST. GALLEN, Switzerland, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sportradar (NASDAQ: SRAD) today announced the appointment of Jim Bombassei as Senior Vice President, Investor Relations and Corporate Finance, effective immediately.
  • Bombassei brings significant financial and investor relations experience to the role having held senior executive positions in the media, technology and gaming industries.
  • He is a talented and respected finance executive, with a wealth of investor relations experience and a track record of success.
  • Prior to that, he spent approximately 30 years at Viacom where he led the company’s corporate finance and investor relations activities.

Dynagas LNG Partners LP Announces Results of 2023 Annual Meeting of Limited Partners

Retrieved on: 
Friday, December 1, 2023

ATHENS, Greece, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of liquefied natural gas carriers, conducted its Annual Meeting of Limited Partners on November 30, 2023, in Athens, Greece.

Key Points: 
  • ATHENS, Greece, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of liquefied natural gas carriers, conducted its Annual Meeting of Limited Partners on November 30, 2023, in Athens, Greece.
  • The following resolutions were approved:
    To elect Dimitris Anagnostopoulos as a Class III Director to serve for a three-year term until the 2026 Annual Meeting of Limited Partners; and
    To ratify the appointment of Ernst & Young (Hellas) Certified Auditors Accountants S.A. as the Partnership’s independent auditors for the fiscal year ending December 31, 2023.

Two Senior Healthcare Industry Professionals Join FTI Consulting’s Healthcare Business Transformation Practice

Retrieved on: 
Thursday, November 30, 2023

WASHINGTON, Nov. 30, 2023 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointments of Leisa Maddoux as a Senior Managing Director and Laura Marston as a Managing Director in the Healthcare Business Transformation practice within the firm’s Corporate Finance & Restructuring segment.

Key Points: 
  • WASHINGTON, Nov. 30, 2023 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointments of Leisa Maddoux as a Senior Managing Director and Laura Marston as a Managing Director in the Healthcare Business Transformation practice within the firm’s Corporate Finance & Restructuring segment.
  • “Leisa and Laura have strong reputations of helping healthcare clients through transformative changes,” said Brian Flynn , Co-Leader of the Healthcare Business Transformation practice.
  • “Health systems today are facing pressures from many angles, whether it’s financial, regulatory or operational.
  • Prior to joining FTI Consulting, Ms. Maddoux was the Global and U.S. Health Transformation practice leader at Ernst & Young, LLP.

CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction

Retrieved on: 
Tuesday, November 28, 2023

The new JV will be located in Riyadh, Saudi Arabia, and operate under the name ‘Lifera Omics’.

Key Points: 
  • The new JV will be located in Riyadh, Saudi Arabia, and operate under the name ‘Lifera Omics’.
  • Lifera Omics will build on this strength with an advanced laboratory and bioinformatics infrastructure, also leveraging the CENTOGENE Biodatabank.
  • In addition, Lifera made an investment in CENTOGENE in the form of a mandatorily convertible loan with a total aggregate principal amount of $30 million.
  • CENTOGENE and Lifera management will be presenting at the Global Healthspan Summit at the Four Seasons Hotel in Riyadh on November 30, 2023.